Pharma-Bio Serv, Inc. (PBSV)
USD 0.55
(0.0%)
USD 0.55
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 346.5 Thousand USD | -28.9% |
| 2022 | 487.36 Thousand USD | -21.06% |
| 2021 | 617.42 Thousand USD | -77.88% |
| 2020 | 2.79 Million USD | 3474.08% |
| 2019 | 78.1 Thousand USD | 30.63% |
| 2018 | 59.79 Thousand USD | -18.92% |
| 2017 | 73.74 Thousand USD | 41.95% |
| 2016 | 51.95 Thousand USD | -30.49% |
| 2015 | 74.73 Thousand USD | -22.74% |
| 2014 | 96.73 Thousand USD | 15.28% |
| 2013 | 83.91 Thousand USD | -31.97% |
| 2012 | 123.34 Thousand USD | -0.03% |
| 2011 | 123.37 Thousand USD | 71.2% |
| 2010 | 72.06 Thousand USD | -32.09% |
| 2009 | 106.12 Thousand USD | 134.17% |
| 2008 | 45.31 Thousand USD | 7.93% |
| 2007 | 41.98 Thousand USD | 8.01% |
| 2006 | 38.87 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 309.56 Thousand USD | -10.66% |
| 2024 Q3 | 233.27 Thousand USD | -14.15% |
| 2024 Q2 | 271.73 Thousand USD | -12.22% |
| 2023 FY | 346.5 Thousand USD | -28.9% |
| 2023 Q2 | 418.2 Thousand USD | -7.74% |
| 2023 Q1 | 453.27 Thousand USD | -6.99% |
| 2023 Q3 | 382.71 Thousand USD | -8.49% |
| 2023 Q4 | 346.5 Thousand USD | -9.46% |
| 2022 Q2 | 553.51 Thousand USD | -5.54% |
| 2022 Q3 | 520.76 Thousand USD | -5.92% |
| 2022 FY | 487.36 Thousand USD | -21.06% |
| 2022 Q4 | 487.36 Thousand USD | -6.41% |
| 2022 Q1 | 585.97 Thousand USD | -5.09% |
| 2021 Q3 | 696.91 Thousand USD | -73.81% |
| 2021 FY | 617.42 Thousand USD | -77.88% |
| 2021 Q2 | 2.66 Million USD | -3.5% |
| 2021 Q4 | 617.42 Thousand USD | -11.41% |
| 2021 Q1 | 2.75 Million USD | -1.22% |
| 2020 Q4 | 2.79 Million USD | -1.18% |
| 2020 FY | 2.79 Million USD | 3474.08% |
| 2020 Q1 | 958.55 Thousand USD | 1127.21% |
| 2020 Q2 | 2.85 Million USD | 198.13% |
| 2020 Q3 | 2.82 Million USD | -1.15% |
| 2019 FY | 78.1 Thousand USD | 30.63% |
| 2019 Q1 | 56.39 Thousand USD | -5.68% |
| 2019 Q2 | 83.4 Thousand USD | 47.89% |
| 2019 Q3 | 80.77 Thousand USD | -3.15% |
| 2019 Q4 | 78.1 Thousand USD | -3.3% |
| 2018 Q4 | 59.79 Thousand USD | -6.25% |
| 2018 Q3 | 63.78 Thousand USD | -4.99% |
| 2018 Q2 | 67.13 Thousand USD | -4.72% |
| 2018 Q1 | 70.45 Thousand USD | -4.46% |
| 2018 FY | 59.79 Thousand USD | -18.92% |
| 2017 FY | 73.74 Thousand USD | 41.95% |
| 2017 Q3 | 77 Thousand USD | 83.18% |
| 2017 Q2 | 42.03 Thousand USD | -8.68% |
| 2017 Q1 | 46.03 Thousand USD | -11.39% |
| 2017 Q4 | 73.74 Thousand USD | -4.24% |
| 2016 Q4 | 51.95 Thousand USD | -10.09% |
| 2016 Q2 | 63.52 Thousand USD | -8.17% |
| 2016 Q1 | 69.17 Thousand USD | -7.44% |
| 2016 FY | 51.95 Thousand USD | -30.49% |
| 2016 Q3 | 57.78 Thousand USD | -9.04% |
| 2015 Q3 | 80.21 Thousand USD | -6.29% |
| 2015 FY | 74.73 Thousand USD | -22.74% |
| 2015 Q1 | 90.89 Thousand USD | -6.04% |
| 2015 Q2 | 85.59 Thousand USD | -5.83% |
| 2015 Q4 | 74.73 Thousand USD | -6.82% |
| 2014 FY | 96.73 Thousand USD | 15.28% |
| 2014 Q2 | 149.25 Thousand USD | 102.92% |
| 2014 Q3 | 138.89 Thousand USD | -6.94% |
| 2014 Q4 | 96.73 Thousand USD | -30.36% |
| 2014 Q1 | 73.55 Thousand USD | -12.35% |
| 2013 Q4 | 83.91 Thousand USD | -10.8% |
| 2013 Q3 | 94.06 Thousand USD | -9.57% |
| 2013 Q2 | 104.02 Thousand USD | -8.58% |
| 2013 Q1 | 113.78 Thousand USD | -7.75% |
| 2013 FY | 83.91 Thousand USD | -31.97% |
| 2012 Q1 | 115.84 Thousand USD | -6.11% |
| 2012 Q2 | 108.14 Thousand USD | -6.65% |
| 2012 Q3 | 100.27 Thousand USD | -7.28% |
| 2012 Q4 | 123.34 Thousand USD | 23.01% |
| 2012 FY | 123.34 Thousand USD | -0.03% |
| 2011 Q1 | 67.64 Thousand USD | -6.14% |
| 2011 FY | 123.37 Thousand USD | 71.2% |
| 2011 Q4 | 123.37 Thousand USD | -5.64% |
| 2011 Q3 | 130.75 Thousand USD | -5.75% |
| 2011 Q2 | 138.72 Thousand USD | 105.09% |
| 2010 FY | 72.06 Thousand USD | -32.09% |
| 2010 Q2 | 88.15 Thousand USD | -5.83% |
| 2010 Q3 | 76.4 Thousand USD | -13.33% |
| 2010 Q1 | 93.61 Thousand USD | -11.79% |
| 2010 Q4 | 72.06 Thousand USD | -5.68% |
| 2009 Q2 | 120.4 Thousand USD | 106.75% |
| 2009 FY | 106.12 Thousand USD | 134.17% |
| 2009 Q4 | 106.12 Thousand USD | -7.49% |
| 2009 Q3 | 114.71 Thousand USD | -4.73% |
| 2009 Q1 | 58.23 Thousand USD | 28.51% |
| 2008 Q1 | 48.46 Thousand USD | 15.44% |
| 2008 Q3 | 50.28 Thousand USD | 1.84% |
| 2008 Q2 | 49.37 Thousand USD | 1.87% |
| 2008 FY | 45.31 Thousand USD | 7.93% |
| 2008 Q4 | 45.31 Thousand USD | -9.88% |
| 2007 Q1 | 39.65 Thousand USD | 2.0% |
| 2007 Q2 | 40.43 Thousand USD | 1.96% |
| 2007 Q3 | 151.65 Thousand USD | 275.11% |
| 2007 Q4 | 41.98 Thousand USD | -72.31% |
| 2007 FY | 41.98 Thousand USD | 8.01% |
| 2006 Q4 | 38.87 Thousand USD | 2.04% |
| 2006 Q2 | 37.31 Thousand USD | 1.2% |
| 2006 FY | 38.87 Thousand USD | 0.0% |
| 2006 Q3 | 38.09 Thousand USD | 2.08% |
| 2006 Q1 | 36.87 Thousand USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Achiko AG | 2.55 Million USD | 86.448% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.6 Million USD | 90.383% |
| Cannabis Sativa, Inc. | 290.22 Thousand USD | -19.395% |
| CompuMed, Inc. | 392.97 Thousand USD | 11.824% |
| CompuGroup Medical SE & Co. KGaA | 846.5 Million USD | 99.959% |
| Cogstate Limited | 672.72 Thousand USD | 48.492% |
| CareView Communications, Inc. | 21.02 Million USD | 98.352% |
| Craneware plc | 35.37 Million USD | 99.02% |
| Caduceus Software Systems Corp. | 2.42 Million USD | 85.726% |
| Certive Solutions Inc. | 5.75 Million USD | 93.98% |
| Drug Free Solution, Inc. | - USD | -Infinity% |
| DATATRAK International, Inc. | 267.41 Thousand USD | -29.579% |
| Strainsforpains, Inc. | 1.93 Million USD | 82.074% |
| Healixa Inc. | 6.59 Million USD | 94.747% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | - USD | -Infinity% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 635.2 Thousand USD | 45.449% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5062.89 USD | -6744.095% |
| iCoreConnect Inc. | 7.87 Million USD | 95.602% |
| IQ-AI Limited | - USD | -Infinity% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | 29.864% |
| Mednow Inc. | 6 Million USD | 94.227% |
| Galileo Life Sciences, Inc. | 20 Thousand USD | -1632.545% |
| MediXall Group, Inc. | 2.82 Million USD | 87.717% |
| Mitesco, Inc. | 1.76 Million USD | 80.387% |
| MobileSmith, Inc. | 5.43 Million USD | 93.621% |
| NantHealth, Inc. | 267.4 Million USD | 99.87% |
| Net Medical Xpress Solutions, Inc. | 949 Thousand USD | 63.487% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 8.53 Million USD | 95.942% |
| Patient Access Solutions, Inc. | 925.37 Thousand USD | 62.555% |
| PPJ Healthcare Enterprises, Inc. | 2.59 Million USD | 86.637% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 59.603% |
| Renalytix Plc | 8.53 Million USD | 95.94% |
| Revium Recovery Inc. | 1000.00 USD | -34550.9% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 27.55 Thousand USD | -1157.746% |
| Vaso Corporation | 2.06 Million USD | 83.179% |
| Vynleads, Inc. | 527.8 Thousand USD | 34.349% |